tiprankstipranks
Advertisement
Advertisement

IMTX Stock Latest News

Immatics Calls 2026 Annual General Meeting, Sets Record Date and Details New Incentive Plan
Company AnnouncementsImmatics Calls 2026 Annual General Meeting, Sets Record Date and Details New Incentive Plan
2d ago
6K
IMTX
Immatics Showcases Strong Phase 1 Data for PRAME and MAGEA4/8 TCR Programs at ASCO 2026
PremiumCompany Announcements
Immatics Showcases Strong Phase 1 Data for PRAME and MAGEA4/8 TCR Programs at ASCO 2026
3d ago
6K
IMTX
Immatics announces presentation of extended data from Phase 1 trial of IMA401
PremiumThe Fly
Immatics announces presentation of extended data from Phase 1 trial of IMA401
3d ago
IMTX
Immatics announces updated Phase 1 data for its Prame TCR T-cell therapy
PremiumThe Fly
Immatics announces updated Phase 1 data for its Prame TCR T-cell therapy
3d ago
IMTX
Immatics reports Q1 EPS (43c), consensus (44c)
PremiumThe Fly
Immatics reports Q1 EPS (43c), consensus (44c)
23d ago
IMTX
Immatics Widens Q1 2026 Loss as Collaboration Revenue Drops, R&D Spend Climbs
PremiumCompany AnnouncementsImmatics Widens Q1 2026 Loss as Collaboration Revenue Drops, R&D Spend Climbs
23d ago
6K
IMTX
Immatics initiated with a Buy at TD Cowen
Premium
The Fly
Immatics initiated with a Buy at TD Cowen
1M ago
IMTX
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
Premium
Company Announcements
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
1M ago
6K
IMTX
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
PremiumCompany Announcements
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
2M ago
6K
IMTX
Immatics abstract accepted for late-breaking poster presentation at AACR meeting
PremiumThe Fly
Immatics abstract accepted for late-breaking poster presentation at AACR meeting
2M ago
IMTX
Immatics assumed with a Buy at Jefferies
PremiumThe Fly
Immatics assumed with a Buy at Jefferies
3M ago
IMTX
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
PremiumCompany Announcements
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
3M ago
6K
IMTX
Immatics sees cash runway into 2028
PremiumThe FlyImmatics sees cash runway into 2028
3M ago
IMTX
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
Premium
The Fly
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
3M ago
IMTX
Immatics price target raised to $25 from $23 at Mizuho
Premium
The Fly
Immatics price target raised to $25 from $23 at Mizuho
3M ago
IMTX
Immatics’ treatment of Stage II and higher CM granted FDA orphan designation
PremiumThe Fly
Immatics’ treatment of Stage II and higher CM granted FDA orphan designation
4M ago
IMTX
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026
PremiumCompany Announcements
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026
5M ago
6K
IMTX
Immatics price target raised to $17 from $14 at BofA
PremiumThe Fly
Immatics price target raised to $17 from $14 at BofA
5M ago
IMTX
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
PremiumCompany Announcements
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
6M ago
6K
IMTX
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
PremiumThe FlyImmatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
6M ago
IMTX
Immatics Completes $116.5 Million Share Offering to Boost R&D
Premium
Company Announcements
Immatics Completes $116.5 Million Share Offering to Boost R&D
6M ago
6K
IMTX
Immatics announces offering of 12.5M ordinary shares
Premium
The Fly
Immatics announces offering of 12.5M ordinary shares
6M ago
IMTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >